Full Year 2020 Xvivo Perfusion AB Earnings Call Transcript
Welcome to the XVIVO Perfusion Report On Operations 2020 Webcast.
I will now hand over to CEO, Dag Andersson. Please go ahead with your meeting.
()-&
Thank you very much. So Dag Andersson, CEO of XVIVO; and Kristoffer Nordstrom, CFO of XVIVO. We are here in Gothenburg today, and we are going to talk about the fourth quarter performance and also summarize 2020 and then talk a little bit about 2021.
I will start by talking a little bit about the highlights, quarter 4. All in all, I am happy with the quarter, I'm happy with the year. Despite the pandemic, we made a lot of progress. And I'm going to show you here a little bit of what our main achievements were, especially in quarter 4. We managed to get the first patients included in the EU Heart preservation study. 4 centers out of 9 are ready to include patients. And we have had patients in Belgium and also at Sahlgrenska Hospital here in Gothenburg, Sweden. So that's a real highlight.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |